Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

The Role of the Selective Adaptor p62 and Ubiquitin-Like Proteins in Autophagy.

Lippai M, Lőw P.

Biomed Res Int. 2014;2014:832704. Epub 2014 Jun 12. Review.

PMID:
25013806
[PubMed - as supplied by publisher]
Free PMC Article
2.

Suppression of tumor angiogenesis by targeting the protein neddylation pathway.

Yao WT, Wu JF, Yu GY, Wang R, Wang K, Li LH, Chen P, Jiang YN, Cheng H, Lee HW, Yu J, Qi H, Yu XJ, Wang P, Chu YW, Yang M, Hua ZC, Ying HQ, Hoffman RM, Jeong LS, Jia LJ.

Cell Death Dis. 2014 Feb 13;5:e1059. doi: 10.1038/cddis.2014.21.

PMID:
24525735
[PubMed - in process]
Free PMC Article
3.

Small molecule-mediated refolding and activation of myosin motor function.

Radke MB, Taft MH, Stapel B, Hilfiker-Kleiner D, Preller M, Manstein DJ.

Elife (Cambridge). 2014 Feb 11;3:e01603. doi: 10.7554/eLife.01603.

PMID:
24520162
[PubMed]
Free PMC Article
4.

Selective growth inhibition of human malignant melanoma cells by syringic acid-derived proteasome inhibitors.

Orabi KY, Abaza MS, El Sayed KA, Elnagar AY, Al-Attiyah R, Guleri RP.

Cancer Cell Int. 2013 Aug 19;13(1):82. doi: 10.1186/1475-2867-13-82.

PMID:
23958424
[PubMed]
Free PMC Article
5.

Ubiquitin at the crossroad of cell death and survival.

Chen YS, Qiu XB.

Chin J Cancer. 2013 Dec;32(12):640-7. doi: 10.5732/cjc.012.10283. Epub 2013 Jul 2.

PMID:
23816559
[PubMed - in process]
Free PMC Article
6.

The tumor suppressor CDKN3 controls mitosis.

Nalepa G, Barnholtz-Sloan J, Enzor R, Dey D, He Y, Gehlhausen JR, Lehmann AS, Park SJ, Yang Y, Yang X, Chen S, Guan X, Chen Y, Renbarger J, Yang FC, Parada LF, Clapp W.

J Cell Biol. 2013 Jun 24;201(7):997-1012. doi: 10.1083/jcb.201205125. Epub 2013 Jun 17. Erratum in: J Cell Biol. 2013 Aug 19;202(4):717.

PMID:
23775190
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.

Zhou W, Wei W, Sun Y.

Cell Res. 2013 May;23(5):599-619. doi: 10.1038/cr.2013.44. Epub 2013 Mar 26. Review.

PMID:
23528706
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

Xie CM, Wei W, Sun Y.

J Genet Genomics. 2013 Mar 20;40(3):97-106. doi: 10.1016/j.jgg.2013.02.001. Epub 2013 Feb 10. Review.

PMID:
23522382
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2.

Davis JR, Mossalam M, Lim CS.

Mol Pharm. 2013 Apr 1;10(4):1340-9. doi: 10.1021/mp300543t. Epub 2013 Mar 1.

PMID:
23398638
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Protein homeostasis as a therapeutic target for diseases of protein conformation.

Calamini B, Morimoto RI.

Curr Top Med Chem. 2012;12(22):2623-40. Review.

PMID:
23339312
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis.

Jo YK, Kim SC, Park IJ, Park SJ, Jin DH, Hong SW, Cho DH, Kim JC.

PLoS One. 2012;7(12):e52705. doi: 10.1371/journal.pone.0052705. Epub 2012 Dec 20.

PMID:
23285162
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo.

Huang H, Liu N, Yang C, Liao S, Guo H, Zhao K, Li X, Liu S, Guan L, Liu C, Xu L, Zhang C, Song W, Li B, Tang P, Dou QP, Liu J.

PLoS One. 2012;7(12):e52576. doi: 10.1371/journal.pone.0052576. Epub 2012 Dec 20.

PMID:
23285100
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The role of allostery in the ubiquitin-proteasome system.

Liu J, Nussinov R.

Crit Rev Biochem Mol Biol. 2013 Mar-Apr;48(2):89-97. doi: 10.3109/10409238.2012.742856. Epub 2012 Dec 13. Review.

PMID:
23234564
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cullin-RING Ligases as attractive anti-cancer targets.

Zhao Y, Sun Y.

Curr Pharm Des. 2013;19(18):3215-25. Review.

PMID:
23151137
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Wei D, Morgan MA, Sun Y.

Transl Oncol. 2012 Oct;5(5):305-12. Epub 2012 Oct 1.

PMID:
23066438
[PubMed]
Free PMC Article
16.

Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1.

Blees JS, Bokesch HR, Rübsamen D, Schulz K, Milke L, Bajer MM, Gustafson KR, Henrich CJ, McMahon JB, Colburn NH, Schmid T, Brüne B.

PLoS One. 2012;7(10):e46567. doi: 10.1371/journal.pone.0046567. Epub 2012 Oct 2.

PMID:
23056346
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Andreoli F, Barbosa AJ, Parenti MD, Del Rio A.

Curr Pharm Des. 2013;19(4):578-613. Review.

PMID:
23016851
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis.

Dai C, Santagata S, Tang Z, Shi J, Cao J, Kwon H, Bronson RT, Whitesell L, Lindquist S.

J Clin Invest. 2012 Oct 1;122(10):3742-54. doi: 10.1172/JCI62727. Epub 2012 Sep 4.

PMID:
22945628
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells.

Yang D, Li L, Liu H, Wu L, Luo Z, Li H, Zheng S, Gao H, Chu Y, Sun Y, Liu J, Jia L.

Cell Death Differ. 2013 Feb;20(2):235-47. doi: 10.1038/cdd.2012.113. Epub 2012 Aug 31.

PMID:
22935614
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Targeting the mTOR-DEPTOR pathway by CRL E3 ubiquitin ligases: therapeutic application.

Zhao Y, Sun Y.

Neoplasia. 2012 May;14(5):360-7. Review.

PMID:
22745582
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk